Navigation Links
Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value

tudies with positive results and the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) is projected for mid-2009.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-donating NCEs, which are in development internally and with partners, including Pfizer Inc and Merck & Co., Inc., for the treatment of prevalent and underserved diseases, such as atherosclerosis, hypertension and widespread eye diseases and respiratory conditions.

NicOx S.A. is headquartered in France and is listed on the NYSE Euronext Paris (Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in the forward-looking statements. For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of NicOx S.A. to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Document de Reference filed with the AMF, which is available on the AMF website ( or on NicOx S.A.'s website (

                          CONSOLIDATED INCOME STATEMENT

                          Fiscal year ended December 31
                                               2008              2007
                                              (in thousands of EUR
                                               except for per share data)

    Revenues.                                 3,362            20,620

    Cost of
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Arpida Announces Full Year 2008 Financial Results
2. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
4. American Oriental Bioengineering, Inc. to Report Fourth Quarter and Full Year 2008 Financial Results on March 9, 2009
5. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
6. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
7. CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results
8. Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2008 Financial Results
9. Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)
10. BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
11. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
Post Your Comments:
(Date:10/8/2015)... -- ATCC, the premier global biological materials resource and standards ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF) ... biotechnology organizations committed to speed a cure for Parkinson,s ... , and more than 5 million worldwide, have Parkinson,s ... , and more than 5 million worldwide, have Parkinson,s ...
(Date:10/8/2015)... 2015 The 2015 Nobel Prize in Chemistry ... at Dallas. Aziz Sancar , who earned his PhD ... in 1977, is one of three scientists who received the ... repair damaged DNA on a molecular level.  --> Aziz ... from UT Dallas in 1977, is one ...
(Date:10/8/2015)... 2015  Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... within its Applied Diagnostics and Testing business segment ... product line with ten certified Snap-N-Spike ® ... and their stable-labeled internal standards. These new solution ... taurocholic acid and native and deuterium-labeled analogs of ...
(Date:10/7/2015)... Oct. 7, 2015 Boston Scientific ... of the Boston Scientific Connected Patient Challenge , ... the use of remote patient monitoring to enhance patient ... entrepreneurs can submit their ideas and collaborate on solutions ... ). Cambridge, MA where ...
Breaking Biology Technology:
... BOONTON, N.J. and BRUSSELS, Sept. 24 Tarsa ... Board: UGNE ) today reported preclinical ... in combination with other drugs in reducing the ... being presented at the 2010 Osteoarthritis Research Society ...
... While scientists have spent the past 40 years describing ... mammalian cell divides into two, they still haven,t agreed ... seemingly contradictory theories, which now may be reconciled by ... Lingchong You. These findings could provide insights into the ...
... Scarguard Labs, LLC, announced achieving the combined ranking of the ... the category according to Information Resources, Inc.,s data ending August 8, ... the prior year for the four week period ending August 8, ... based on dollar sales for the same four week period. ...
Cached Biology Technology:
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, ... today that it has signed a contract with the ... across the full range of sentences under the Department,s ... of the Americas. "This contract with the Virginia DOC ... the US and advances our position as a trusted ...
(Date:10/5/2015)... 5, 2015 ) ... NXT-ID, Inc. (NASDAQ: NXTD ), a biometric authentication ... --> ) releases the following ... NXTD ), a biometric authentication company focused on the ... Group ( ) releases the following ...
(Date:10/1/2015)... 2015  Biometrics includes diverse set of technologies ... such as fingerprints, eye retinas, facial patterns, voice ... technology has been constantly increasing in ... In addition to the most prominent popular method ... means of biometric authentication are rapidly gaining traction ...
Breaking Biology News(10 mins):
... vaccine principle is being developed by scientists at the University ... expected potential could help to save millions of lives ... is known, represents an advance on the original DNA vaccines ... consists of a chain of amino acids attached to a ...
... researcher Dr. Danny Reinberg was awarded a Howard Hughes ... on ant epigenetics- helping to unravel the impact lifestyle ... what ants can teach us about aging and behavior. ... species including humans, using gene regulation in ants as ...
... probably the largest contaminant of our body. That this ... has not been proven convincingly. The current Editorial of ... reflects on this and concludes that this proof ... take measures to reduce our exposure from all ...
Cached Biology News:
Request Info...
... Source: E. coli containing a clone of ... Description: Topoisomerase II alters the topological state ... helix through a transient break which generates a ... of its double-stranded DNA passage mechanism, the enzyme ...
Request Info...
... Cell Expansion Kit - Neurosphere is a system ... cell expansion as neurospheres in a serum free ... Plus Media Supplement, which has been optimized for ... al . (1996) Genes & Development 10 ...
Biology Products: